Albiglutide

Active ingredient description

Albiglutide is an agonist of the GLP-1 receptor and augments glucose-dependent insulin secretion. Albiglutide also slows gastric emptying.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
A10BJ04
A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BJ Glucagon-like peptide-1 (GLP-1) analogues
Discover more medicines within A10BJ04

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title
Information Source
Document Type
 
EPERZAN Powder and solvent for solution for injection
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)

External identifiers

CAS Substance: 782500-75-8
DrugBank Drug: DB09043
KEGG Drug: D08843
PubChem Compound: 145994868
RxNorm Ingredient: 1534763
SNOMED-CT Concept: 703129009
Albiglutide (substance)
UNII Identifier: 5E7U48495E
ALBIGLUTIDE

Medicines

Albiglutide is an active ingredient of these brands:

Estonia (EE)

Lithuania (LT)

While we strive to include the brand names of medicines across all countries, our index remains incomplete. Therefore, it is possible that this medicine may also be marketed under different names in other countries.

 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈